HomeNewscoronavirusIndia reports over 8,000 new COVID-19 cases after 103 days, 10 fatalities in last 24 hours

India reports over 8,000 new COVID-19 cases after 103 days, 10 fatalities in last 24 hours

A total of 8,329 new coronavirus cases were reported in a span of 24 hours, while the death toll due to the disease has climbed to 5,24,757, with 10 fatalities being recorded.

June 11, 2022 / 10:05 IST
(Image: Reuters)

A single-day rise of over 8,000 fresh COVID-19 cases was recorded in the country after 103 days, pushing India's infection tally to 4,32,13,435, while the count of active cases jumped to 40,370, according to Union Health Ministry data on Saturday.

A total of 8,329 new coronavirus cases were reported in a span of 24 hours, while the death toll due to the disease has climbed to 5,24,757, with 10 fatalities being recorded, the data updated at 8 am showed.

The active cases now comprise 0.09 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.69 per cent, the ministry said. An increase of 4,103 cases has been recorded in the active COVID-19 caseload in a span of 24 hours, the data showed.

The daily positivity rate was recorded at 2.41 per cent and the weekly positivity rate at 1.75 per cent, according to the health ministry. The number of people who have recuperated from the disease has surged to 4,26,48,308, while the case fatality rate was recorded at 1.21 per cent.

The cumulative number of doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 194.92 crore.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5, 50 lakh on September 16, 60 lakh on September 28, 70 lakh on October 11, 80 lakh on October 29, 90 lakh on November 20 and the one-crore mark on December 19, 2020.

The country crossed the grim milestones of two crore cases on May 4, 2021, and three crore on June 23.

PTI
first published: Jun 11, 2022 10:03 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347